THE WHOLE POT
LATEST SOUP
Everything currently simmering, newest batch first.
-
Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction
On August 12, 2026, the Drug Enforcement Administration (DEA) published a temporary order placing O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA published this temporary order…
-
Certain Hydrodermabrasion Systems and Components Thereof; Notice of Vacatur of the Commission’s Final Determination and Mootness of the Investigation by the Federal Circuit Due to Patent Expiration
Notice is hereby given that the U.S. International Trade Commission’s (“Commission”) final determination in the above- captioned investigation has been vacated by the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) and the investigation is terminated as moot as ordered by the Federal Circuit. The investigation was previously terminated on March 23, 2026.
-
Agency Information Collection Activities; Comment Request; Integrated Postsecondary Education Data System (IPEDS) 2026-27 Through 2028-29
In accordance with the Paperwork Reduction Act (PRA) of 1995, the Department is proposing a revision of a currently approved information collection request (ICR).
-
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA’s Table of Exempted Prescription Products, but whose National Drug Codes (NDC) are inactive because they are no longer available and/or the company that applied for the exemption no longer exists. These products will be removed…